Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Bae

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|September 15, 2001
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycinK S Yu, J Y Cho, J H Shon, et al.
Molecules and Cells|February 24, 2001
Flow cytometric analysis and chromosome sorting of barley (hordeum vulgare L)J H Lee, K Arumuganathan, Y S Chung, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Amycolatopsis thermoflava sp. nov., a novel soil actinomycete from Hainan Island, ChinaJ Chun, S B Kim, Y K Oh, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysisS H Kang, M R Poynton, K M Kim, et al.
The Journal of Antibiotics|November 18, 2000
cis-fumagillin, a new methionine aminopeptidase (type 2) inhibitor produced by Penicillium sp. F2757J Y Kwon, H W Jeong, H K Kim, et al.
Journal of Korean Medical Science|August 21, 2001
Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?K Y Na, J S Han, Y S Kim, et al.
Clinical Pharmacology and Therapeutics|April 20, 2001
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19K S Yu, D S Yim, J Y Cho, et al.
Journal of Clinical Pharmacology|July 7, 2000
Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersI J Jang, K S Yu, J H Shon, et al.
British Journal of Cancer|February 18, 2011
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activityK-p Kim, G Jang, Y S Hong, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|September 15, 2001
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycinK S Yu, J Y Cho, J H Shon, et al.
Molecules and Cells|February 24, 2001
Flow cytometric analysis and chromosome sorting of barley (hordeum vulgare L)J H Lee, K Arumuganathan, Y S Chung, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Amycolatopsis thermoflava sp. nov., a novel soil actinomycete from Hainan Island, ChinaJ Chun, S B Kim, Y K Oh, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysisS H Kang, M R Poynton, K M Kim, et al.
The Journal of Antibiotics|November 18, 2000
cis-fumagillin, a new methionine aminopeptidase (type 2) inhibitor produced by Penicillium sp. F2757J Y Kwon, H W Jeong, H K Kim, et al.
Journal of Korean Medical Science|August 21, 2001
Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?K Y Na, J S Han, Y S Kim, et al.
Clinical Pharmacology and Therapeutics|April 20, 2001
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19K S Yu, D S Yim, J Y Cho, et al.
Journal of Clinical Pharmacology|July 7, 2000
Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersI J Jang, K S Yu, J H Shon, et al.
British Journal of Cancer|February 18, 2011
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activityK-p Kim, G Jang, Y S Hong, et al.
Pageof 4